Adjuvant Dapagliflozin in Kidney Transplant Recipients with Diabetes and Heart Failure—An Observational Exploratory Study
<b>Background</b>: Kidney transplant recipients (KTRs) with diabetes mellitus (DM) are at high cardiovascular risk, and heart failure (HF) is a major concern. Dapagliflozin has proven benefits in HF, but data in KTRs are scarce. <b>Methods</b>: Retrospective analysis of adult KTRs with DM and HF who...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2026-06-01
|
| Collection: | Diabetology |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2673-4540/7/6/110 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|